CytomX Therapeutics, Inc. (CTMX) Net income 2016–2025
CytomX Therapeutics, Inc. (CTMX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.4MFY2025 · since FY2016: -$58.9M → -$17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.4M | -154.5% |
| FY2024 | $31.9M | +5700.9% |
| FY2023 | -$569,000 | +99.4% |
| FY2022 | -$99.3M | +14.3% |
| FY2021 | -$115.9M | -78.8% |
| FY2020 | -$64.8M | +51.2% |
| FY2019 | -$132.8M | -57.0% |
| FY2018 | -$84.6M | -96.3% |
| FY2017 | -$43.1M | +26.8% |
| FY2016 | -$58.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice